MedPath

Oxidized Cellulose hEmostAsis evaluatioN

Not Applicable
Completed
Conditions
Intra-operative Bleeding
Registration Number
NCT01637025
Lead Sponsor
Baxter Healthcare Corporation
Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of Traumastem to help stop bleeding in participants undergoing open cardiac, intra-abdominal (including retroperitoneal) and pelvic surgery as compared to Surgicel® Original (Surgicel; in some countries marketed as Tabotamp®)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
111
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Occurrence of adverse events (AEs)/ adverse device effects (ADEs)≤30 ± 5 days/ end-of-study visit after device application

Occurrence of adverse events (AEs)/ adverse device effects (ADEs) up to 30 ± 5 days/ end-of-study visit after device application.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (23)

Chirurgicke oddeleni Nemocnice Liberec

🇨🇿

Liberec, Czech Republic

Kardiochirurgicke oddeleni FN Plzen

🇨🇿

Plzen - Lochotin, Czech Republic

Chirurgicka klinika FN KV

🇨🇿

Praha, Czech Republic

Chirurgicka klinika UVN

🇨🇿

Praha, Czech Republic

Chirurgicke oddeleni Fakultni nemocnice Na Bulovce

🇨🇿

Praha, Czech Republic

Kardiochirurgicka klinika FN KV

🇨🇿

Praha, Czech Republic

Klinika kardiovaskularni chirurgie IKEM

🇨🇿

Praha, Czech Republic

Klinik für Allgemein-, Visceral- und Transplantationschirurgie Charité Berlin

🇩🇪

Berlin, Germany

Klinik für Allgemein-, Visceral-, Gefäß- und Thoraxchirurguie Charité Universitätsmedizin Berlin - Campus Mitte

🇩🇪

Berlin, Germany

Allgemein- und Viszeralchirurgie Johann Wolfgang Goethe Universitätsklinikum

🇩🇪

Frankfurt am Main, Germany

Scroll for more (13 remaining)
Chirurgicke oddeleni Nemocnice Liberec
🇨🇿Liberec, Czech Republic

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.